Valuation: Phaarmasia Limited

Market Cap 614M 6.41M 5.63M 5.29M 4.84M 9.04M 9.11M 63.56M 24.64M 313M 24.09M 23.56M 1.02B P/E 2025
-12.6x
P/E 2026 2.92x
Enterprise Value 517M 5.4M 4.74M 4.46M 4.07M 7.61M 7.67M 53.53M 20.75M 264M 20.29M 19.84M 855M EV / Sales 2025
0.81x
EV / Sales 2026 0.88x
Free-Float
-
Yield 2025 *
-
Yield 2026 -
1 week+5.88%
Current month-10.02%
1 month+18.42%
3 months-7.13%
6 months+12.84%
Current year-20.17%
1 week 82.65
Extreme 82.65
90
1 month 76
Extreme 76
104.95
Current year 67
Extreme 67
131.75
1 year 30.01
Extreme 30.01
131.75
3 years 23.51
Extreme 23.51
131.75
5 years 20.2
Extreme 20.2
131.75
10 years 10.3
Extreme 10.3
131.75
Manager TitleAgeSince
Director of Finance/CFO - 2016-02-11
Compliance Officer - 2020-01-02
Director TitleAgeSince
Chairman 71 2010-10-13
Director/Board Member 55 2012-12-08
Director/Board Member 63 2012-12-18
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+5.88%+125.00%+243.51% 6.43M
-1.81%+0.98%+53.82%+108.05% 1,043B
-0.47%-0.14%+51.15%+66.54% 649B
-0.14%+0.86%+18.94%+71.21% 469B
-0.25%+0.19%+36.95%+45.54% 355B
+0.98%+2.91%+20.59%+27.14% 270B
-1.91%+2.42%+10.41%+11.04% 262B
-0.90%+8.19%+41.97%+52.58% 222B
-1.38%+2.05%+31.74%+101.40% 189B
-2.53%-7.47%-32.63%-60.41% 175B
Average -0.78%+2.57%+35.79%+66.66% 363.3B
Weighted average by Cap. -0.91%+2.19%+35.56%+64.92%

Financials

2025 2026
Net sales 244M 2.54M 2.23M 2.1M 1.92M 3.59M 3.61M 25.21M 9.77M 124M 9.55M 9.34M 403M 472M 4.93M 4.33M 4.07M 3.72M 6.95M 7M 48.84M 18.93M 241M 18.51M 18.1M 780M
Net income -15.89M -166K -146K -137K -125K -234K -236K -1.64M -637K -8.1M -623K -609K -26.27M 176M 1.83M 1.61M 1.51M 1.38M 2.59M 2.6M 18.18M 7.05M 89.59M 6.89M 6.74M 290M
Net Debt -1.94M -20.22K -17.75K -16.68K -15.25K -28.5K -28.71K -200K -77.68K -988K -75.94K -74.27K -3.2M -96.98M -1.01M -889K -835K -764K -1.43M -1.44M -10.03M -3.89M -49.44M -3.8M -3.72M -160M
Logo Phaarmasia Limited
Phaarmasia Limited is an India-based company, which is primarily engaged in the manufacturing and sale of oral contraceptive pills (OCPs). The Company manufactures and markets oral contraceptive tablets with various therapeutic dosage combinations along with iron tablets for the Ministry of Health & Family Welfare and for exports. Its product categories include Hormone Products and Herbal Products. Its hormone products include Estradiol Valerate Tablets; Medroxyprogesterone Acetate Tablets; Cabergoline Tablets; Clomiphene Citrate Tablets; Levonorgestrel Tablet; Fluoxymesterone tablets; Liothyronine Sodium tablets; Oxandrolone tablets and others. Its herbal products include Smyle Herbal Toothpaste; Smyle Cough & Sore Throat Reliver and Smyle Mouth Ulcer Gel. Its injectables include Testosterone Cypionate Injection; Methenolone Enanthate Injection; Drostanolone, Testosterone and Trenbolone Inj, and Stanozolol Cypionate Inj.
Employees
47
Date Price Change Volume
26-09-23 90.00 0.00% 127
26-09-22 ₹90.00 +3.45% 580
26-09-21 ₹87.00 -1.14% 238
26-09-18 ₹88.00 -1.12% 213
26-09-17 ₹89.00 -0.28% 620
  1. Stock Market
  2. Stocks
  3. PHRMASI6 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!